Mesoblast's market cap is currently ―. The company's EPS TTM is $-1.063; its P/E ratio is -4.71; Mesoblast is scheduled to report earnings on May 29, 2024, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Dec 22	Sep 22	Jun 22	Mar 22
Income Statement	-
Total Revenue	-	$ 1.98M	$ 1.44M	$ 2.22M	$ 2.01M
Gross Profit	-	-	-	-	-
EBIT	-	$ -19.65M	$ -12.39M	$ -17.10M	$ -17.05M
EBITDA	-	$ -18.57M	$ -11.28M	$ -16.03M	$ -15.94M
Net Income Common Stockholders	-	$ -24.49M	$ -16.88M	$ -21.45M	$ -21.30M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 71.51M	$ 67.22M	$ 85.11M	$ 60.03M	$ 76.31M
Total Assets	$ 669.41M	$ 668.06M	$ 684.50M	$ 662.14M	$ 681.69M
Total Debt	$ 116.50M	$ 111.78M	$ 109.63M	$ 106.91M	$ 104.65M
Net Debt	$ 44.98M	$ 44.56M	$ 24.52M	$ 46.87M	$ 28.34M
Total Liabilities	$ 167.58M	$ 168.06M	$ 161.69M	$ 165.10M	$ 164.56M
Stockholders Equity	$ 501.84M	$ 500.00M	$ 522.81M	$ 497.04M	$ 517.13M
Cash Flow	-
Free Cash Flow	-	$ -16.49M	$ -14.49M	$ -13.94M	$ -15.53M
Operating Cash Flow	-	$ -16.45M	$ -14.29M	$ -13.89M	$ -15.47M
Investing Cash Flow	-	$ -34.00K	$ -203.00K	$ -47.00K	$ -56.00K
Financing Cash Flow	-	$ -2.01M	$ 40.30M	$ -2.22M	$ -2.57M

Currency in USD

Mesoblast Earnings and Revenue History

Income Statement >

Mesoblast Debt to Assets

Balance Sheet >

Mesoblast Cash Flow

Cash Flow >

Mesoblast Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing